Skip to content

Altimmune

US · ALT #3727 by market cap
1.33 -0.08 -5.67%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:01

Price chart

Pre-market 1.38 -2.13%
After-hours 1.35 +1.83%
Overnight 1.42 +0.71%
3.421.331.332026-05-262026-11-20
MA5MA10MA20MA60
— MA5 — MA10 — MA20 — MA60
Reader sentiment Are you bullish or bearish on ALT?

Anonymous reader poll. Unscientific, not investment advice.

✦ StockVane Quant Insights how this is computed

Quant Sentiment Bearish
  • Recent price momentum is -62.6% on average (3-month/1-year).
  • Main-fund capital flow has been a net outflow over the last 45 sessions.
  • Short interest has risen to 21.7% of float.
  • Analyst tilt is Buy.
Quant Technical Outlook Bearish
  • Price is below its 20-day average and below its 60-day average.
  • The 20-day average is below the 60-day average, a short-term downtrend.
Quant Rating, last 30 days E → E

Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.

Performance

1W -19.15%
1M -42.17%
3M -54.92%
6M -52.84%
YTD -63.16%
1Y -70.25%
3Y -49.43%
5Y -87.39%

Key statistics

Price & volume

Prev close
1.41
Open
1.37
Day range
1.32 - 1.46
Avg price
1.36
Volume
4.06M
Turnover
5.52M
Amplitude
9.93%
52-week range
1.32 - 6.44

Valuation

P/E
-1.33
P/E (TTM)
-1.87
P/B
0.58
EPS
-1.00
Net profit
-194.59M
Net assets
443.66M

Share structure

Market cap
258.80M
Float cap
231.84M
Shares out
194.59M
Float shares
174.31M

Dividend & listing

Dividend (TTM)
0.00
Listing date
--
52-week range 0% of range
1.32 6.44

79.3% below the 52-week high

Trading activity

Net capital flow main funds, last 45 sessions

-4.86M net over the window

Short interest

Shares short
42.13M
As of
2026-10-30

Frequently asked questions

What is the current stock price of Altimmune (ALT)?

Altimmune last traded at 1.33. This page shows a periodic quote snapshot. Check the displayed quote time.

What is Altimmune's market cap?

About 258.80M.

What is the P/E ratio of Altimmune?

The trailing twelve-month P/E is -1.87. The Valuation tab shows it against the stock's own five-year range.

Does Altimmune pay a dividend?

Altimmune does not currently pay a regular dividend.

Is Altimmune a buy according to analysts?

The consensus of 2 analysts is a Buy rating, with an average 12-month price target of 18.50, which implies 1291.0% upside from the current price. This is not investment advice.

What is Altimmune's StockVane Quant Rating?

The StockVane Momentum strategy currently rates Altimmune a E (Strong Sell). Below its 200-day average and near the bottom of the universe on momentum. Not investment advice.

Quote time 2026-11-20 20:01:10 · For reference only, not investment advice and not tailored to your situation.

Altimmune discussion 0 comments

Add a comment